Utah Retirement Systems’s AbbVie ABBV Stock Holding History

Utah Retirement Systems’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.6M	Sell	288,031 -4,671	-2%	-$1.04M	0.64%	21
2025 Q4	$66.9M	Buy	292,702 +41	+0%	+$9.34K	0.64%	18
2025 Q3	$67.8M	Buy	292,661 +613	+0.2%	+$125K	0.66%	21
2025 Q2	$54.2M	Sell	292,048 -1,468	-0.5%	-$273K	0.57%	23
2025 Q1	$61.5M	Sell	293,516 -410	-0.1%	-$79.7K	0.71%	22
2024 Q4	$52.2M	Buy	293,926 +700	+0.2%	+$129K	0.58%	23
2024 Q3	$57.9M	Buy	293,226 +1,300	+0.4%	+$243K	0.65%	22
2024 Q2	$50.1M	Sell	291,926 -14,400	-5%	-$2.39M	0.59%	23
2024 Q1	$55.8M	Buy	306,326 +100	+0%	+$17.2K	0.65%	22
2023 Q4	$47.5M	Buy	306,226 +1,800	+0.6%	+$262K	0.6%	23
2023 Q3	$45.4M	Buy	304,426 +1,500	+0.5%	+$220K	0.65%	21
2023 Q2	$40.8M	Sell	302,926 -12,000	-4%	-$1.76M	0.57%	24
2023 Q1	$50.2M	Buy	314,926 +1,000	+0.3%	+$153K	0.73%	20
2022 Q4	$50.7M	Sell	313,926 -3,000	-0.9%	-$460K	0.8%	20
2022 Q3	$42.5M	Buy	316,926 +2,200	+0.7%	+$316K	0.71%	21
2022 Q2	$48.2M	Sell	314,726 -700	-0.2%	-$107K	0.77%	21
2022 Q1	$51.1M	Sell	315,426 -5,100	-2%	-$741K	0.68%	21
2021 Q4	$43.4M	Buy	320,526 +700	+0.2%	+$82.7K	0.54%	31
2021 Q3	$34.5M	Sell	319,826 -17,000	-5%	-$1.94M	0.47%	42
2021 Q2	$37.9M	Sell	336,826 -1,600	-0.5%	-$180K	0.49%	35
2021 Q1	$36.6M	Sell	338,426 -14,900	-4%	-$1.59M	0.51%	34
2020 Q4	$37.9M	Buy	353,326 +15,100	+4%	+$1.45M	0.54%	34
2020 Q3	$29.6M	Buy	338,226 +2,200	+0.7%	+$207K	0.49%	37
2020 Q2	$33M	Buy	336,026 +53,780	+19%	+$4.74M	0.61%	30
2020 Q1	$21.5M	Hold	282,246	–	–	0.47%	44
2019 Q4	$25M	Buy	282,246 +1,000	+0.4%	+$83K	0.44%	43
2019 Q3	$21.3M	Sell	281,246 -300	-0.1%	-$20.6K	0.41%	50
2019 Q2	$20.5M	Sell	281,546 -4,817	-2%	-$379K	0.39%	51
2019 Q1	$23.1M	Buy	286,363 +3,758	+1%	+$307K	0.46%	40
2018 Q4	$26.1M	Buy	282,605 +700	+0.2%	+$61.6K	0.59%	30
2018 Q3	$26.7M	Sell	281,905 -12,200	-4%	-$1.16M	0.52%	35
2018 Q2	$27.2M	Sell	294,105 -2,800	-0.9%	-$273K	0.56%	33
2018 Q1	$28.1M	Buy	296,905 +400	+0.1%	+$43.9K	0.6%	31
2017 Q4	$28.7M	Buy	296,505 +4,100	+1%	+$386K	0.6%	31
2017 Q3	$26M	Buy	292,405 +400	+0.1%	+$30.4K	0.58%	33
2017 Q2	$21.2M	Sell	292,005 -4,800	-2%	-$323K	0.49%	38
2017 Q1	$19.3M	Buy	296,805 +400	+0.1%	+$25.1K	0.46%	42
2016 Q4	$18.6M	Hold	296,405	–	–	0.47%	38
2016 Q3	$18.7M	Hold	296,405	–	–	0.48%	40
2016 Q2	$18.4M	Sell	296,405 -1,600	-0.5%	-$97.5K	0.49%	43
2016 Q1	$17M	Buy	298,005 +1,100	+0.4%	+$61.3K	0.46%	43
2015 Q4	$17.6M	Buy	296,905 +300	+0.1%	+$17.3K	0.48%	42
2015 Q3	$16.1M	Sell	296,605 -15,000	-5%	-$976K	0.46%	43
2015 Q2	$20.9M	Buy	311,605 +27,402	+10%	+$1.79M	0.56%	34
2015 Q1	$16.6M	Buy	284,203 +9,000	+3%	+$544K	0.44%	48
2014 Q4	$18M	Hold	275,203	–	–	0.5%	40
2014 Q3	$15.9M	Sell	275,203 -600	-0.2%	-$33.3K	0.46%	43
2014 Q2	$15.6M	Sell	275,803 -8,600	-3%	-$451K	0.45%	41
2014 Q1	$14.6M	Buy	284,403 +2,000	+0.7%	+$101K	0.42%	47
2013 Q4	$14.9M	Hold	282,403	–	–	0.44%	45
2013 Q3	$12.6M	Sell	282,403 -2,400	-0.8%	-$106K	0.41%	50
2013 Q2	$11.8M	Buy	+284,803	New	+$12.5M	0.4%	52

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Utah Retirement Systems's ABBV Position: Q1 2026 in Review

Utah Retirement Systems reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $1.04M and leaving 288,031 shares worth $62.6M. The position accounts for 0.64% of the portfolio, ranked #21.

Utah Retirement Systems first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $67.8M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Utah Retirement Systems held 288,031 shares of AbbVie worth $62.6M as of Q1 2026.
Utah Retirement Systems sold 4,671 AbbVie shares in Q1 2026, an estimated $1.04M.
AbbVie made up 0.64% of Utah Retirement Systems's portfolio in Q1 2026, its #21 holding.
Utah Retirement Systems first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Utah Retirement Systems's AbbVie position peaked at $67.8M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Utah Retirement Systems's 13F filing for Q1 2026, filed 15 May 2026.